Superselective uterine arterial embolization with pingyangmycin-lipiodol emulsion for management of symptomatic uterine leiomyoma / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 75-78, 2004.
Article
em En
| WPRIM
| ID: wpr-235829
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>BACKGROUND</b>Uterine arterial embolization (UAE) is a safe and effective therapy for symptomatic uterine leiomyoma. This study was to assess the effectiveness and the feasibility of pingyangmycin-lipiodol emulsion (PLE) for the management of symptomatic uterine leiomyoma.</p><p><b>METHODS</b>One hundred consecutive patients (aged 21 - 53 years, with 38 in average) with symptomatic uterine leiomyoma underwent superselective UAE with PLE. Clinical symptoms of the patients (including menorrhagia, bulk-related symptoms, and postprocedure-related abdominal pain) and the changes in uterine volume and tumor size after the embolization were analyzed. The patients were followed up for 8 - 21 months (mean, 15 months).</p><p><b>RESULTS</b>Ninety-nine patients (99%, 99/100) were interviewed in their first menses circle after embolization, showing improvements in their abnormal bleeding and bulk-related symptoms to some extent. Imagiological results during follow-up showed a mean of 48% reduction in uterine volume at 6 months and a mean of 75% reduction in tumor size at 9 months. Eighty-three percent of the patients reported complete resolution of postprocedure pain within 7 days.</p><p><b>CONCLUSIONS</b>PLE is effective in the management of uterine leiomyoma, having superiority in alleviating postprocedure-related pain.</p>
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Terapêutica
/
Neoplasias Uterinas
/
Útero
/
Bleomicina
/
Seguimentos
/
Óleo Iodado
/
Meios de Contraste
/
Embolização Terapêutica
/
Emulsões
/
Leiomioma
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Idioma:
En
Revista:
Chinese Medical Journal
Ano de publicação:
2004
Tipo de documento:
Article